Price (delayed)
$0.062
Market cap
$112,870
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$6.7
Enterprise value
-$31.95M
Advaxis, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Lm-based antigen delivery products. These immunotherapies are based on a platform technology that utilizes live
There are no recent dividends present for ADXS.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.